38 reports

IV. CARDIOVASCULAR DRUGS PRODUCTION AND DEMAND

  • Cardiovascular Drug
  • China
  • Industrial Production
  • Labour Force

Abstract: - Global Cardiovascular Drugs Market to Reach $80 Billion by 2027 - Amid the COVID-19 crisis, the global market for Cardiovascular Drugs estimated at US$79.8 Billion in the year 2020, is projected to reach a revised size of US$80 Billion by 2027, growing at a CAGR of 0% over the analysis period 2020-2027....

  • Cardiovascular Drug
  • World
  • China
  • United States

GLOBAL CARDIOVASCULAR DRUGS MARKET

  • Cardiovascular Disease
  • Cardiovascular Drug
  • In-Store Retail
  • World
  • Europe
  • North America
  • APAC
  • South America
  • Middle East
  • Cause-Specific Mortality Rate
  • Elderly Population

Major companies in the cardiovascular drugs market include Merck & Co; Sanofi S.A; Pfizer Inc; Bristol-Myers Squibb Company and Novartis AG. The global cardiovascular drugs market is expected to grow from $87.79 billion in 2020 to $92.41 billion in 2021 at a compound annual growth rate (CAGR) of 5.3%. The growth is mainly due to the...

  • Cardiovascular Drug
  • World
  • Chronic Disease Prevalence
  • Labour Utilisation

IV. CARDIOVASCULAR DRUGS PRODUCTION AND DEMAND

  • Cardiovascular Drug
  • China
  • Industrial Production
  • Labour Force

Empty Capsules Market Size, Outlook and Growth Opportunities, 2019- 2025 Global Empty Capsules Market Size, Outlook and Growth Opportunities to 2025: By Type (Gelatin Capsules, Non-Gelatin Capsules), By Functionality (Immediate-Release Capsules, Sustained-Release Capsules, and Delayed-Release Capsules), By Application...

  • Pharmaceutical
  • Healthcare
  • Anti-Infective
  • Cardiovascular Drug
  • Cough And Cold
  • Nutraceutical
  • Gelatin
  • Dietary Supplement
  • Analgesic
  • Cosmetics
  • World
  • APAC
  • Asia
  • Europe
  • North America
  • Middle East
  • Africa
  • Latin America
  • Health Expenditure

This report was created for global strategic planners who cannot be content with traditional methods of segmenting world markets. With the advent of a "borderless world", cities become a more important criteria in prioritizing markets, as opposed to regions, continents, or countries. This report covers the top 2,000 cities in over 200 countries....

  • Cardiovascular Drug
  • World

This study covers the world outlook for cardiovascular drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative...

  • Cardiovascular Drug
  • World
  • Gross Domestic Product
  • Disposable Income

Report Scope: This report provides detailed exposure of the cardiovascular drugs market, highlighting major cardiovascular diseases with detailed epidemiology for the primary disease areas. The report includes an industrywide assessment of the novel product launches, recent approvals, research and development pipeline,...

  • Cardiovascular Drug
  • World

Brazil Food Production Cardiovascular Drug

  • Cardiovascular Drug
  • Central America
  • Biologics Penetration Rate
  • Food Production

Cardiovascular Drug

  • Cardiovascular Drug
  • Middle East
  • Africa
  • Health Expenditure
  • Biologics Penetration Rate

United States North America Cardiovascular Drug

  • Cardiovascular Drug
  • North America
  • Biologics Penetration Rate
  • Surgical Procedures Performed

Europe Pharmaceutical Exports Cardiovascular Drug

  • Cardiovascular Drug
  • Europe
  • Pharmaceutical Exports
  • Pharmaceutical Production

APAC Medical Technology Density Cardiovascular Drug

  • Cardiovascular Drug
  • APAC
  • Biologics Penetration Rate
  • Pharmaceutical Production

World Cardiovascular Drug

  • Cardiovascular Drug
  • World
  • APAC
  • Pharmaceutical Production
  • Health Expenditure

World Cardiovascular Drug

  • Cardiovascular Drug
  • World
  • APAC
  • Pharmaceutical Production
  • Health Expenditure

North America Cardiovascular Drug Hormone

  • Hormone
  • Cardiovascular Drug
  • North America
  • Allergy Prevalence
  • Drug Approval

Europe Cardiovascular Drug Hormone

  • Hormone
  • Cardiovascular Drug
  • Europe
  • Prescription Drug Sales
  • Allergy Prevalence

APAC Cardiovascular Drug Hormone

  • Hormone
  • Cardiovascular Drug
  • APAC
  • Allergy Prevalence
  • Drug Approval

Global Cardiovascular Drugs Market: Overview Cardiovascular drugs are widely used for treating various heart related dysfunction.With increasing number of cardiovascular diseases across the globe is the major driving factor for the growth of the cardiovascular diseases. According to the study conducted by Global...

  • Cardiovascular Drug
  • World
  • Young Population

World Hospital Admission Cardiovascular Drug Hormone

  • Hormone
  • Cardiovascular Drug
  • World
  • Health Expenditure
  • Hospital Admission

United Arab Emirates Cardiovascular Drug Hormone

  • Hormone
  • Cardiovascular Drug
  • APAC
  • United States
  • World
  • Europe
  • Allergy Prevalence
  • Health Expenditure

World Cardiovascular Drug Therapy

  • Drug Development
  • Cardiovascular Drug
  • World
  • Drug Approval
  • Cancer Mortality

World Cardiovascular Drug Therapy

  • Drug Development
  • Liver Cancer
  • Cardiovascular Drug
  • World
  • Drug Approval

World Cardiovascular Drug Therapy

  • Cardiovascular Drug
  • World
  • Drug Approval

This study covers the latent demand outlook for cardiovascular drugs across the states, union territories, and cities of India. Latent demand (in millions of U.S. dollars), or potential industry earnings (P.I.E.) estimates are given across over 4,900 cities in India. For each city in question, the percent share the city is of its state...

  • Cardiovascular Drug
  • India
  • United States
  • Disposable Income
  • Purchasing Power Parity

This study covers the latent demand outlook for cardiovascular drugs across the regions of China, including provinces, autonomous regions (Guangxi, Nei Mongol, Ningxia, Xinjiang, Xizang - Tibet), municipalities (Beijing, Chongqing, Shanghai, and Tianjin), special administrative regions (Hong Kong and Macau), and Taiwan (all hereafter referred...

  • Cardiovascular Drug
  • China
  • Disposable Income
  • Purchasing Power Parity

This study covers the latent demand outlook for cardiovascular drugs across the states and cities of the United States. Latent demand (in millions of U.S. dollars), or potential industry earnings (P.I.E.) estimates are given across some 12,600 cities in the United States. For each city in question, the percent share the city is of its...

  • Cardiovascular Drug
  • United States
  • Disposable Income
  • Purchasing Power Parity

Cardiovascular Drugs Market Trends And Strategies

  • Cardiovascular Drug
  • World
  • Health Expenditure
  • Drug Approval

APAC World Biopharmaceutical Cardiovascular Drug

  • Therapy
  • Healthcare
  • Biopharmaceutical
  • Cardiovascular Drug
  • Clinical Trial
  • Hospital
  • World
  • Disposable Income
  • Gross Domestic Product